Could a common drug change how opioids work in the body?
Knowledge-focused
Completed
This early-stage trial is testing whether an experimental oral suspension called QEV-817 (doxapram) changes how the body handles the opioid hydrocodone. Healthy volunteers aged 18-55 will receive hydrocodone with and without doxapram to compare safety and drug levels in the blood…
Phase: PHASE1 • Sponsor: Quivive Pharma, Inc. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC